Jump to content

Christopher Savoie

Add links
From Wikipedia, the free encyclopedia
Dr.
Christopher Savoie
Savoie in 2019
Born (1971-01-19) January 19, 1971 (age 55)
Warwick, Rhode Island[1]
CitizenshipUnited States
Japan
OccupationsEntrepreneur, scientist, lawyer
Known forCo-inventor of natural language technology that contributed to the development of Siri[1][2][3]

Christopher Savoie (born January 19, 1971) is an American-Japanese entrepreneur, scientist, and lawyer. He has co-founded or led multiple ventures including Dejima Inc.,[4] Gene Networks International (GNI),[5] Kyulux,[6] and Zapata Computing,[7][8][9] with work spanning computational biology, natural-language systems, quantum algorithms, and industrial agentic AI. He is currently the co-founder and CEO of SiC Systems.[2] During his time at Dejima, his patented work on artificial intelligence with Babak Hodjat led to the technology used by Apple for their digital assistant Siri.[10][3][1]

Career

[edit]

Informatics and early ventures

[edit]

As a student in Japan, Savoie worked across computational biology and informatics, publishing on peptide motif inference in immunology and applying machine learning to epitope prediction.[11][12] He also contributed to work on peptide-binding groove dynamics.[13] Savoie established early web consultancies including Atmark and Webula[4] during the dot-com boom.

Dejima and natural-language systems

[edit]

In 1998, Savoie co-founded Dejima Inc. with Babak Hodjat and Makoto Amamiya to develop adaptive, agent-oriented architectures for natural-language interfaces.[14][15][16] The Adaptive Agent Oriented Software Architecture (AAOSA) approach that Savoie invented with Hodjat at Dejima was later used by Apple as the natural language interface in their digital assistant Siri.[1][17]

Gene Networks International (GNI)

[edit]

In 2001, Savoie co-founded Gene Networks International (GNI) based on his research on the application of Bayesian machine learning for systems pharmacology and drug design.[18][19] Savoie served as the CEO and led the company through an IPO on the Tokyo Stock Exchange on August 31, 2007. [20] As of December 13th, 2025, GNI Group Ltd. has a market cap of $880M.[21]

Nissan

[edit]

Savoie later served as Senior Manager of Enterprise Architecture at Nissan, where he worked on big-data analytics and AI for global processes.[19]

Kyulux

[edit]

In 2015, Savoie co-founded and served as CEO at Kyulux. The company applied machine learning methods to identify light-emitting molecules that require less energy to emit colored light for OLED displays. [17]

Zapata Computing

[edit]

In 2023, Zapata rebranded as Zapata AI with a focus on developing quantum-inspired generative AI applications for industrial-scale problems. In April 2024, Zapata AI became a public company listed on the NASDAQ stock exchange through a business combination with Andretti Acquisition Corp., a SPAC created by Michael Andretti.[22][7][23] In October 2024, the company announced it was ceasing operations.[24][25] In September 2025, the company announced a restart as Zapata Quantum, with a renewed focus on developing quantum computing software applications for enterprise use cases. [26][27]

SiC Systems

[edit]

In 2025, Savoie co-founded SiC Systems, a Nashville-based venture applying agentic AI to biomanufacturing and specialty chemicals.[2]

[edit]

Savoie has served on the steering committee of the U.S. Quantum Economic Development Consortium (QED-C).[28] In 2023, he was named QED-C Quantum Law Chair.[29][30] He has also served as vice chair of the Big Data committee of the American Bar Association.[29]

Honors and awards

[edit]
  • 1999 MIT Technology Review Innovators Under 35[4]

Selected patents and publications

[edit]

Patents

  • US US6594684B1, Hodjat, Babak; Savoie, Christopher J.; Amamiya, Makoto, "Adaptive agent-oriented software architecture", issued 2000-11-07[15]
  • US US6144989, Hodjat, Babak; Savoie, Christopher J.; Amamiya, Makoto, "Adaptive interaction using an adaptive agent-oriented software architecture", issued 2003-07-15[31]
  • US US6772190B2, Hodjat, Babak; Savoie, Christopher J.; Amamiya, Makoto, "Distributed parser of natural language input", issued 2004-08-03[32]
  • US US7430475B2, Imoto, Seiyo; Goto, Takao; Miyano, Satoru; Tashiro, Kosuke; De Hoon, Michiel; Savoie, Christopher J.; Kuhara, Saturo, "Biological discovery using gene regulatory networks generated from multiple-disruption expression libraries", issued 2008-09-30[33]
  • US US7761499B2, Hodjat, Babak; Savoie, Christopher J.; Amamiya, Makoto, "System for automated reply to natural language input", issued 2010-07-20[34]

Publications

  • Sudo, Tohru; Kamikawaji, Nobuhiro; Kimura, Akinori; Date, Yukiji; Savoie, Christopher; Nakashima, Hisashi; Furuichi, Emiko; Kuhara, Satoru; Sasazuki, Takehiko (1995-11-15). "Differences in MHC class I self peptide repertoires among HLA-A2 subtypes". The Journal of Immunology. 155 (10): 4749–4756.[12]
  • Imoto, Seiya; Savoie, Christopher J.; Aburatani, Sachiyo; Kim, Sunyong; Tashiro, Kousuke; Kuhara, Satoru; Miyano, Satoru (2003). "Use of Gene Networks for Identifying and Validating Drug Targets". Journal of Bioinformatics and Computational Biology. 01 (03): 459–474.[35]
  • Savoie, Christopher; Aburatani, Sachiyo; Watanabe, Shouji; Eguchi, Yoshihiro; Muta, Shigeru; Imoto, Seiya; Miyano, Satoru; Kuhara, Satoru; Tashiro, Kosuke (2003-01-01). "Use of Gene Networks from Full Genome Microarray Libraries to Identify Functionally Relevant Drug-affected Genes and Gene Regulation Cascades". DNA Research. 10 (1): 19–25.[36]
  • Hurley, Daniel; Araki, Hiromitsu; Tamada, Yoshinori; Dunmore, Ben; Sanders, Deborah; Humphreys, Sally; Affara, Muna; Imoto, Seiya; Yasuda, Kaori; Tomiyasu, Yuki; Tashiro, Kosuke; Savoie, Christopher; Cho, Vicky; Smith, Stephen; Kuhara, Satoru; Miyano, Satoru; Charnock-Jones, D. Stephen; Crampin, Edmund J.; Print, Cristin G. (2012). "Gene network inference and visualization tools for biologists: application to new human transcriptome datasets". Nucleic Acids Research. 40 (6): 2377–2398.[37]
  • Kailasanathan, Rajiv; Clements, William R.; Boskabadi, Mohammad Reza; Gibford, Shawn M.; Papadakis, Emmanouil; Savoie, Christopher J.; Mansouri, Seyed Soheil (2025-08-29). "Quantum enhanced ensemble GANs for anomaly detection in continuous biomanufacturing". arXiv.org.[38]

References

[edit]
  1. ^ a b c d "Quantum Quest". The University of Rhode Island. 2019-03-25. Retrieved 2025-11-18.
  2. ^ a b c Adams, Lucy (2025-10-14). "Siri inventor raises over €2M for quantum startup". Tech.eu. Retrieved 2025-12-01.
  3. ^ a b "Christopher Savoie '92". The University of Rhode Island. 2025-11-17. Retrieved 2025-11-18.
  4. ^ a b c "Christopher J. Savoie". Innovators Under 35. Retrieved 2025-12-01.
  5. ^ "About us". Gene Networks International. Retrieved 2025-12-01.
  6. ^ Tremblay, Jean-François (2016-10-31). "Kyulux". Chemical & Engineering News. Retrieved 2025-12-01.
  7. ^ a b Bort, Julie (2024-01-19). "Today's GenAI models are cost and energy pigs. Quantum tech could fix that". Business Insider. Retrieved 2025-12-08.
  8. ^ Keane, Jonathan (2022-06-07). "The race toward a new computing technology is heating up". CNBC. Retrieved 2025-12-01.
  9. ^ Ray, Tiernan (2020-11-19). "Quantum computing now is a bit like SQL was in the late 80s: Wild and wooly and full of promise". ZDNET. Retrieved 2025-12-08.
  10. ^ Swayne, Matt (2021-01-20). "TQD Exclusive: With A Front-Row Seat, Zapata's CEO Sees Reason for Excitement — But Not Hype — In Quantum". The Quantum Insider. Retrieved 2025-12-08.
  11. ^ Savoie, C. J.; Kamikawaji, N.; Sasazuki, T.; Kuhara, S. (1998). "Use of BONSAI decision trees for the identification of potential MHC Class I peptide epitope motifs". Biocomputing '99. WORLD SCIENTIFIC. pp. 182–189. doi:10.1142/9789814447300_0018. ISBN 978-981-02-3624-3. Retrieved 2025-12-13.
  12. ^ a b T, Sudo; N, Kamikawaji; A, Kimura; Y, Date; CJ, Savoie; H, Nakashima; E, Furuichi; S, Kuhara; T, Sasazuki (1995). "Differences in MHC class I self peptide repertoires among HLA-A2 subtypes". Journal of Immunology. 155 (10): 4749–4756. doi:10.4049/jimmunol.155.10.4749. ISSN 0022-1767. PMID 7594476.
  13. ^ Toh, Hidehiro; Savoie, Christopher J.; Kamikawaji, Nobuhiro; Muta, Shigeru; Sasazuki, Takehiko; Kuhara, Satoru (2000-10-15). "Changes at the floor of the peptide-binding groove induce a strong preference for Proline at position 3 of the bound peptide: Molecular dynamics simulations of HLA-A*0217". Biopolymers. 54 (5): 318–327. doi:10.1002/1097-0282(20001015)54:5<318::AID-BIP30>3.0.CO;2-T. ISSN 0006-3525. PMID 10935972. Retrieved 2025-12-13.
  14. ^ "2025 Company Profile & Team". Tracxn. 2023-01-19. Retrieved 2025-12-13.
  15. ^ a b Hodjat, Babak; Savoie, Christopher J.; Amamiya, Makoto (2000-11-07). "Adaptive agent-oriented software architecture: US 6144989 A". Google Patents. Archived from the original on 2016-05-22. Retrieved 2017-12-14.
  16. ^ Tremblay, Jean-François (2016-06-06). "In the Land of the Rising Sun, the climate improves for high-technology start-ups". Chemical & Engineering News. Retrieved 2025-12-13.
  17. ^ a b Tremblay, Jean-François (2025-10-01). "Kyulux". Chemical & Engineering News. Retrieved 2025-12-13.
  18. ^ "Company Overview and Group Structure". 株式会社ジーエヌアイグループ (in Japanese). Retrieved 2025-12-13.
  19. ^ a b "Quantum Computing in 2022". MIT Sloan Club of New York. 2023-04-10. Retrieved 2025-12-13.
  20. ^ "Japan's GNI completes IPO". The Pharmaletter. 2007-09-09. Retrieved 2025-12-13.
  21. ^ "GNI Group Ltd. (2160.T) Stock Price, News, Quote & History". Yahoo Finance. Retrieved 2025-12-13.
  22. ^ Pressman, Aaron (2024-04-02). "Quantum computing. Generative AI. Harvard startup Zapata goes public with all the buzzwords". BostonGlobe.com. Retrieved 2025-12-13.
  23. ^ Baker, Liana (2023-09-06). "Michael Andretti's SPAC Finds Tech Target in Zapata AI". Bloomberg.com. Retrieved 2025-12-13.
  24. ^ Swayne, Matt (2024-10-12). "Zapata Computing Holdings Inc. Ceases Operations". The Quantum Insider. Retrieved 2025-12-13.
  25. ^ Pressman, Aaron (2024-10-15). "Boston quantum computing startup Zapata Computing goes bust". BostonGlobe.com. Retrieved 2025-12-13.
  26. ^ Swayne, Matt (2025-09-03). "Viva Zapata -- Zapata Quantum Reemerges After Bankruptcy Filing With Restructuring and New Financing". The Quantum Insider. Retrieved 2025-12-13.
  27. ^ "'That pivot ... really didn't work out:' Zapata Quantum CEO tells comeback story". Boston Business Journal. 2025-11-25. Retrieved 2025-12-13.
  28. ^ Admin, QED-C (2020-09-11). "QED-C Steering Committee member Christopher Savoie breaks down the three steps toward becoming a quantum-capable organization". QED-C. Retrieved 2025-12-01.
  29. ^ a b AI, Zapata (2023-12-15). "Zapata AI CEO Christopher Savoie Appointed 2024 QED-C Quantum Law Chair". Business Wire. Retrieved 2025-12-01.
  30. ^ Hertz, Jake (2025-05-20). "Generative AI for Dirty Jobs—The Next Industrial Revolution?". Engineering Podcast. Retrieved 2025-12-01.
  31. ^ US US6144989, Hodjat, Babak; Savoie, Christopher J.; Amamiya, Makoto, "Adaptive interaction using an adaptive agent-oriented software architecture", issued 2003-07-15 
  32. ^ US US6772190B2, Hodjat, Babak; Savoie, Christopher J.; Amamiya, Makoto, "Distributed parser of natural language input", issued 2004-08-03 
  33. ^ US US7430475B2, Imoto, Seiyo; Goto, Takao; Miyano, Satoru; Tashiro, Kosuke; De Hoon, Michiel; Savoie, Christopher J.; Kuhara, Saturo, "Biological discovery using gene regulatory networks generated from multiple-disruption expression libraries", issued 2008-09-30 
  34. ^ US US7761499B2, Hodjat, Babak; Savoie, Christopher J.; Amamiya, Makoto, "System for automated reply to natural language input", issued 2010-07-20 
  35. ^ Imoto, Seiya; Savoie, Christopher J.; Aburatani, Sachiyo; Kim, Sunyong; Tashiro, Kousuke; Kuhara, Satoru; Miyano, Satoru (2003). "Use of Gene Networks for Identifying and Validating Drug Targets". Journal of Bioinformatics and Computational Biology. 01 (3): 459–474. doi:10.1142/S0219720003000290. ISSN 0219-7200. PMID 15290765. Retrieved 2025-11-25.
  36. ^ Savoie, C. J. (2003-01-01). "Use of Gene Networks from Full Genome Microarray Libraries to Identify Functionally Relevant Drug-affected Genes and Gene Regulation Cascades". DNA Research. 10 (1): 19–25. doi:10.1093/dnares/10.1.19. ISSN 1340-2838. PMID 12693551. Retrieved 2025-11-25.
  37. ^ Hurley, Daniel; Araki, Hiromitsu; Tamada, Yoshinori; Dunmore, Ben; Sanders, Deborah; Humphreys, Sally; Affara, Muna; Imoto, Seiya; Yasuda, Kaori; Tomiyasu, Yuki; Tashiro, Kosuke; Savoie, Christopher; Cho, Vicky; Smith, Stephen; Kuhara, Satoru; Miyano, Satoru; Charnock-Jones, D. Stephen; Crampin, Edmund J.; Print, Cristin G. (2012). "Gene network inference and visualization tools for biologists: application to new human transcriptome datasets". Nucleic Acids Research. 40 (6): 2377–2398. doi:10.1093/nar/gkr902. ISSN 1362-4962. PMC 3315333. PMID 22121215.
  38. ^ Kailasanathan, Rajiv; Clements, William R.; Boskabadi, Mohammad Reza; Gibford, Shawn M.; Papadakis, Emmanouil; Savoie, Christopher J.; Mansouri, Seyed Soheil (2025-08-29). "Quantum enhanced ensemble GANs for anomaly detection in continuous biomanufacturing". arXiv:2508.21438 [cs.LG].
Retrieved from "https://en.wikipedia.org/w/index.php?title=Christopher_Savoie&oldid=1356317357"